128: Machine Learning Algorithms to Predict Seizure Control in Epilepsy Surgery
NeurologyLive® Mind Moments® - A podcast by NeurologyLive - Fridays
Categories:
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, Lara Jehi, MD, MHCDS, an epilepsy specialist and Cleveland Clinic’s Chief Research and Information Officer, sat down to discuss a recently published study that explored using machine learning algorithms to predict seizure control after epilepsy surgery. In the interview, Jehi explained the unique aspects of the study design, emphasizing the importance of a large, well-characterized patient cohort with consistent follow-up and the choice of scalp EEG—a commonly used, non-invasive test in epilepsy care—as the data source. In addition, Jehi touched on the use of AutoML to streamline the process, enabling efficient identification of the top-performing algorithms and enhancing the model’s predictive accuracy. Furthermore, she spoke on the team needed to properly implement machine learning techniques for neurosurgery, while providing recommendations for other institutions interested in pursuing these types of approaches. Looking for more epilepsy discussion? Check out the NeurologyLive® epilepsy clinical focus page. Episode Breakdown: 1:00 – Background on various machine learning approaches for epilepsy research 3:20 – Study details, findings, and notable takeaways 8:20 – Neurology News Minute 10:20 – Novelty in using scalp EEG and its global application 15:30 – Team personnel needed for proper implementation of machine learning techniques in epilepsy surgery The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy FDA Places Clinical Hold on Epilepsy Agent RAP-219 for Diabetic Peripheral Neuropathic Pain First-Ever CRISPR/Cas13-RNA Editing Therapy to be Tested in Phase 1 Study of Age-Related Macular Degeneration Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.